Wolverine Trading’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Wolverine Trading’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-30,200	Closed	-$543K	–	5487
2020 Q2	$543K	Sell	30,200 -11,500	-28%	-$160K	﹤0.01%	2654
2020 Q1	$304K	Buy	41,700 +12,900	+45%	+$161K	﹤0.01%	3207
2019 Q4	$687K	Sell	28,800 -13,100	-31%	-$361K	﹤0.01%	2769
2019 Q3	$1.12M	Sell	41,900 -3,600	-8%	-$101K	﹤0.01%	1873
2019 Q2	$1.23M	Buy	45,500 +15,600	+52%	+$489K	﹤0.01%	1864
2019 Q1	$1.04M	Sell	29,900 -6,800	-19%	-$196K	﹤0.01%	2037
2018 Q4	$627K	Buy	36,700 +13,900	+61%	+$286K	﹤0.01%	2419
2018 Q3	$607K	Buy	+22,800	New	+$744K	﹤0.01%	2877

Wolverine Trading's PTLA Position: Q2 2020 in Review

Wolverine Trading sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 40,332 shares — an estimated $561K sold.

Wolverine Trading first reported a position in PTLA in Q3 2018 and held it in 7 quarters. The position peaked at $1.07M in Q1 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

Wolverine Trading reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Wolverine Trading sold 40,332 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $561K.
Wolverine Trading first reported a position in Portola Pharmaceuticals, Inc. in Q3 2018 and held it in 7 quarters.
Wolverine Trading's Portola Pharmaceuticals, Inc. position peaked at $1.07M in Q1 2019.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Wolverine Trading's 13F filing for Q2 2020, filed 13 Aug 2020.